Ridiculousness! RXMD keeps listening to shareholders and acting accordingly. RXMD could have uplisted yesterday, but shareholders like me were vocal that we don't want to uplist from $0.05, and it didn't happen! Congratulations RXMD Longs! Thank you RXMD!